Streetbeat News

Stock Prices

PSX

Phillips 66 plans to perform discretionary maintenance on its refineries in Q3. The company reported that crude utilization reached 98% in Q2, the highest in over 5 years.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 5:02 pm

COTY

EL

LRLCY

Coty shares are trading lower in sympathy with Estee Lauder after L'Oreal reported worse-than-expected Q2 sales results.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 5:02 pm

CVS

Deep-pocketed investors have shown a bullish approach towards CVS Health (NYSE:CVS) with significant options activity detected. The options market indicates a price range of $32.5 to $70.0 for CVS Health over the next three months. The stock is currently trading at $63.07, up by 2.44%, with an earnings announcement expected in 8 days.

Portfolio Pulse from Benzinga Insights

July 30, 2024 | 5:01 pm

AVGO

Broadcom (NASDAQ:AVGO) has seen unusual options activity with a bullish stance from significant investors. Out of 89 trades, 52 were calls and 37 were puts, with a total trade value of $6,311,122 for calls and $3,398,909 for puts. Analysts maintain high target prices, and the stock is currently down by 3.08% at $145.6.

Portfolio Pulse from Benzinga Insights

July 30, 2024 | 5:01 pm

QCOM

Recent unusual options activity for Qualcomm (NASDAQ:QCOM) indicates a bearish sentiment among big-money investors, with 53% of trades being bearish. The stock is currently down by 4.93% and is approaching oversold territory. Analysts have mixed ratings, with price targets ranging from $200 to $250.

Portfolio Pulse from Benzinga Insights

July 30, 2024 | 5:01 pm

AMG

Eight financial analysts have recently provided ratings on Affiliated Managers Group (NYSE: AMG), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased to $202.25, up 2.73% from the previous target. Analysts have adjusted their ratings and price targets in response to market conditions and company performance. AMG's financial performance shows a decline in revenue growth and net margin, but strong ROE and ROA, and a conservative debt management approach.

Portfolio Pulse from Benzinga Insights

July 30, 2024 | 5:01 pm

BMY

ORCL

PFE

TXT

The CNBC Halftime Report highlighted final trades including Bristol-Myers Squibb, Pfizer, Textron, and Oracle.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 5:00 pm

CRWD

DAL

MSFT

CrowdStrike's recent security mishap, which caused a global IT outage affecting Microsoft systems, is expected to impact the company's revenue and market share for the next year. Despite the setback, Needham maintains a Buy rating on CrowdStrike but lowers the price target. Delta Air Lines is seeking compensation for the disruption. CrowdStrike's stock has dropped significantly since the incident.

Portfolio Pulse from Michael Juliano

July 30, 2024 | 5:00 pm

SYM

Symbotic, Inc. (NASDAQ:SYM) stock is trading lower after reporting worse-than-expected Q3 earnings and issuing Q4 guidance below estimates. The company reported a loss of two cents per share, missing analyst estimates, but beat sales expectations with $491.86 million. Analysts have adjusted their price targets following the report.

Portfolio Pulse from Dylan Berman

July 30, 2024 | 4:59 pm

INCY

Incyte Corporation (NASDAQ: INCY) reported Q2 revenue of $1.04 billion, beating expectations, but posted a wider-than-expected EPS loss of $(1.82). Jakafi sales guidance was raised, and Opzelura showed strong growth. The company announced a strategic pipeline review and positive Phase 3 results for retifanlimab. William Blair maintains an Outperform rating with a $89 price target.

Portfolio Pulse from Vandana Singh

July 30, 2024 | 4:57 pm